Drug-induced liver Injury (DILI) remains a major problem for drug development and a clinical concern after marketing. We need new understanding, and a path forward to solve the problems. This academic-industry-government international conference will discuss new findings and thinking about DILI, including presentations by experts in clinical hepatology, toxicology, and other fields, and lively discussions with all registrants. The program is co-sponsored by the Food and Drug Administration/Center for Drug Evaluation and Research (FDA/CDER), Critical Path Institute (C-Path), and Pharmaceutical Research and Manufacturers of America (PhRMA). The progarm is endorsed by the National Institutes of Health (NIH) and the Drug-Induced Liver Injury Network (DILIN).
WhenWednesday, March 20, 2013 8:00 AM - Thursday, March 21, 2013 4:00 PMEastern Time
WhereMarriott Inn & Conference CenterUniversity of MarylandUniversity College3501 University Blvd.East Hyattsville, Maryland 20783
FeesEvent RegistrationGovernment or Academia
View Event Summary
View Event Agenda
RSVPTuesday, March 19, 2013
Please respond by clicking one of the buttons below